Tuesday, May 21, 2013

Witnesses for House Hearing on May 23, 2013 on Examining Drug Compounding

Examining Drug Compounding

Thursday, May 23, 2013 - 10:00am
2322 Rayburn
Background Documents and Information: 
Panel I

Janet Woodcock, M.D.
  • Director
  • Center for Drug Evaluation and Research
  • Food and Drug Administration (FDA)
Panel II
Scott Gottlieb, M.D.
  • Resident Fellow
  • American Enterprise Institute
Joseph H. Harmison
  • Owner, Harmison Pharmacies
  • On behalf of National Community Pharmacist Association
Gerry Migliaccio
  • Quality Systems Consultant
  • Migliaccio Consulting
Elizabeth Scott (Scotti) Russell
  • Government Affairs Manager
  • National Association of Boards of Pharmacy
Gabrielle Cosel
  • Manager, Drug Safety 
  • The Pew Charitable Trusts

No comments: